ClosedUnited Kingdom
BCU-STA-63056 Purchase of Blood Analyser for Glan Clwyd Hospital Theatres
- Published
- Published 18 June 2026
Overview
Betsi Cadwaladr University Health Board has awarded a contract worth £48,000 to Novel Biomarkers Catalyst Lab (NBCL BV) for the supply of a specialist blood analyser to Glan Clwyd Hospital Theatres, following a successful equipment trial. The analyser will standardise equipment and practice with the unit already in use at Wrexham Maelor Hospital Theatres and is intended to reduce waiting lists for this specialty procedure. The contract is now in delivery/complete.
Key details
- Country
- United Kingdom
- Status
- Closed
- Procedure
- Direct
- Published
- 18 June 2026
Award outcome
- Awarded value
- £48,000
- Award date
- 15 June 2026
- Contract period
- 30 June 2026 → 1 July 2026
- Novel Biomarkers Catalyst Lab (NBCL BV)
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
18 June 2026
View notice ↗Contract
18 June 2026
View notice ↗
Contracting authority
Betsi Cadwaladr University Health Board
BuyerBangor, United Kingdom
GB-NHS: 7A1
Authority website ↗NHS Wales Shared Services Partnership
Procuring entitySt Asaph, United Kingdom
GB-NHS: RQF
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.